Gastrointestinal Surgery Nutrition Market to Reach USD 1,128.3 Million by 2036, US – CAGR 7.0%, UK – CAGR 6.7%

Gastrointestinal Surgery Nutrition Market

The global gastrointestinal surgery nutrition market is projected to grow from USD 557.7 million in 2026 to USD 1,128.3 million by 2036, registering a 7.3% CAGR during the forecast period. Demand is supported by the growing use of nutrition screening, early oral feeding, enhanced-recovery pathways, and structured nutrition support before and after gastrointestinal procedures. Hospitals are increasingly incorporating pre-operative carbohydrate drinks, oral supplements, and enteral formulas into planned surgical workflows.

Enhanced-recovery programmes are creating defined points for nutrition use across the surgical pathway, from pre-assessment and pre-operative preparation to immediate post-operative feeding and home recovery. The growing number of gastrointestinal procedures is also increasing demand for products with clear dosage, timing, and tolerance information. At the same time, connected recovery programmes and adherence support are creating opportunities for suppliers to extend nutrition product use beyond hospitals into discharge and homecare settings.

Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-35654

Global Segment Leaders

  • Product Type – Pre-Op Carbohydrate Drinks: 43.6% in 2026. The segment leads as these products can be administered at a scheduled time before selected elective procedures, allowing hospitals to integrate nutrition into pre-operative instructions.
  • Surgery Type – Colorectal: 48.1% in 2026. Colorectal procedures represent a major application area as enhanced-recovery pathways can incorporate nutrition screening, carbohydrate drinks, and early oral feeding during preparation and recovery.
  • Phase – Pre-Operative: 50.2% in 2026. Pre-operative nutrition leads as hospitals can assess nutrition risk, oral intake, and product tolerance before surgery and establish product timing in advance.
  • End User – Hospitals: 46.6% in 2026. Hospitals remain the leading end users because surgical teams, dietitians, pharmacies, and clinical teams can coordinate product selection, administration, and discharge instructions within the same setting.
  • Sales Channel – Hospital Pharmacy: 46.5% in 2026. Hospital pharmacies remain important for scheduled ward supply, batch purchasing, and controlled access to oral supplements and enteral formulas.

Country-Level Performance

South Korea is projected to record the fastest growth among the profiled countries, with a 7.8% CAGR through 2036. Growth is supported by the adoption of minimally invasive colorectal surgery and the concentration of procedures in larger hospitals. A nationwide Korean analysis recorded 109,573 colorectal cancer resections from 2019 to 2023, with minimally invasive surgery reaching 84.7% in 2023.

The United States is forecast to grow at a 7.0% CAGR, supported by its large colorectal cancer treatment base and the use of hospital order sets for pre-operative preparation and post-operative nutrition. The CDC reported 155,662 new colorectal cancers in the United States during 2023.

The United Kingdom is projected to expand at a 6.7% CAGR through 2036. Enhanced-recovery programmes support nutrition before admission and early eating and drinking after surgery. West Suffolk NHS Foundation Trust’s colorectal programme includes nourishing drinks before admission, a carbohydrate preload on surgery day, and nutritional drinks following surgery.

Germany is expected to register a 6.0% CAGR, supported by a large base of intestinal procedures and opportunities for nutrition screening and feeding around gastrointestinal surgery. Destatis reported 381,456 other intestinal operations and 213,445 local excision or destruction procedures of the large intestine during 2024.

Japan is forecast to grow at a 5.4% CAGR, with demand influenced by institution-specific perioperative pathways, product acceptance, and continued evaluation of colorectal procedures.

Regional Context

South Korea and the United States represent two of the faster-growing profiled markets, with CAGRs of 7.8% and 7.0%, respectively. South Korea benefits from established colorectal enhanced-recovery practices and high adoption of minimally invasive procedures, while the United States benefits from a large surgical treatment base and established hospital nutrition pathways.

The United Kingdom and Germany represent established European markets, with CAGRs of 6.7% and 6.0%, respectively. Their growth is supported by enhanced-recovery programmes, hospital-based nutrition screening, and structured perioperative care. Japan records a 5.4% CAGR, reflecting more institution-specific pathways and product acceptance.

The full report covers North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, and the Middle East and Africa, with individual country analysis.

Access full Report in PDF Format@ https://www.futuremarketinsights.com/reports/brochure/rep-gb-35654

Competitive Landscape

The competitive landscape includes Nestlé Health Science, Abbott, Danone Nutricia, Fresenius Kabi, B. Braun, Kate Farms, Medtrition, and Enhanced Medical Nutrition. Competition spans perioperative nutrition platforms, hospital oral and enteral nutrition, peptide-based formulas, modular nutrition products, and solutions supporting continued nutrition during home recovery.

Recent developments include Danone’s majority acquisition of Kate Farms in July 2025, combining hospital, home, online, and retail access for specialized nutrition. Enhanced Medical Nutrition has also developed a programme combining perioperative products with provider dashboards for adherence and consumption, supporting the extension of nutrition management into home recovery.

Analyst Perspective from Future Market Insights notes that protocol-led nutrition is expected to shift demand toward products with clear timing and tolerance, while suppliers connecting hospital use with home recovery could benefit from stronger repeat demand.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

FMI

FMI

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favour the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.